Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $110,219
Award facts
- Contract value 100% obligated
- $110,219.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,219.22 by the Defense Logistics Agency on November 10, 2025, with an ultimate completion date of November 12, 2025. This delivery order, issued without set-aside designation, is executed under the company's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order authorizes DMS Pharmaceutical Group to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, consistent with the company's established role as a critical supplier within the federal military medical supply chain.
This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division throughout October and November 2025. The parent IDC, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning the company as a regional prime vendor within the broader $30.3 billion PPV-G GEN V acquisition strategy. DMS Pharmaceutical Group's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals including oncology treatments and immunosuppressants, and medical consumables to support the diverse pharmaceutical requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FEMMQ?
SPE2DU26FEMMQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DU26FEMMQ worth?
The government has obligated $110,219 on SPE2DU26FEMMQ.
Is contract SPE2DU26FEMMQ an order under another contract?
Yes. SPE2DU26FEMMQ is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMQ competed?
The extent of competition for SPE2DU26FEMMQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award